Aptah Bio
Biotechnology ResearchView the employees at
Aptah Bio-
Igor Austin, MD, MBA Abdominal Radiologist | Johns Hopkins MBA | Advancing Treatments for Age-Related Diseases
-
Baltimore
-
Rising Star
Camila Guimarães Moreira Zimmer, PhD Head of Preclinical Research & Development-
Florianópolis, Santa Catarina, Brazil
-
Rising Star
Vanessa Sinatti, PhD Head of Bioinformatics-
Copenhagen, Capital Region, Denmark
-
Rising Star
Caio Leal Chief Scientific Officer na APTAH Bio Inc-
San Carlos, California, United States
-
Rising Star
Higor Falcão CSO and Co-founder - Business Development and Strategy at Aptah Bioinformatic.-
Brasília
-
Rising Star
Overview
Imagine a world where age-related diseases are things of the past! That’s the potential Aptah Bio is unlocking. We are working with leading global scientists, laboratories and the best patent attorneys to develop the next pharmaceutical blockbuster with a multi-billion dollar market value, able to impact the lives of millions of people. Aptah developed a unique and powerful therapy that will revolutionize how age-related diseases are treated by delivering the only and first compound to work as a genome-wide transcription modulator, correcting multiple mRNAs and toxic proteins.
-